Noelle Acosta
![](https://pdtueu.com/sites/default/files/styles/panopoly_image_square/public/speakers/edited-12927_hh-73817248_noelle_acosta_9920-2.jpg?itok=28nzwLqP&c=7e219dd6fc2100a9f04582421e0111e3)
Noelle Acosta
Noelle Acosta is the Co-Founder & CEO of Noula Health, a digital health company that provides personalized reproductive health care for women and birthing people via at-home precision health testing and 1-on-1 virtual support from experts. Noelle is one of less than 100 Latina female founders to have ever raised over $1M for her startup. Prior to Noula, Noelle has helped lead and scale sales and business development teams at startups in the Bay Area and New York City. Noelle is also a certified birth doula and passionate about accessible, equitable healthcare for all.
David Stern
David Stern has over 28 years of women’s health experience and has devoted the majority of his career to the fertility industry. He has held executive leadership positions and built successful teams while launching numerous products in pharmaceutical and biotech markets world-wide. Currently, David serves as the CEO of Boston IVF, one the largest IVF center networks in the United States with 11 full service IVF centers and over 30 satellite centers nationwide.
David served as CEO of Symbiomix Therapeutics a venture backed biotech company. He led the transition of the company from development stage to commercial launch in the US, prior to its acquisition by Lupin Pharmaceuticals in 2017. He served on the board of California Cryobank and has held executive positions in startup companies in the women’s healthcare market, building commercial teams, developing strategy and expanding scientific partnerships for Celmatix, Ohana and OvaScience.
David was the Senior Vice President and Head of the Global Business Franchise for Fertility at Merck Serono, responsible for the strategic development and growth of the portfolio world-wide. Prior to his global role, he was responsible for the US commercial operations in the Fertility, HIV and Growth Hormone markets. David started his career in women’s health with Organon Pharmaceutics. He has an MBA with a concentration in International Marketing and Management from the F.W. Olin School of Business at Babson College and holds a Bachelors’ degree in Biology from Brandeis University.
![](https://pdtueu.com/sites/default/files/styles/panopoly_image_square/public/speakers/tom_maidment.jpg?itok=9ptNStjt&c=edbf1cd6dabc3b7bcc4200d9da2e59e6)
Tom Maidment
![](https://pdtueu.com/sites/default/files/styles/panopoly_image_square/public/speakers/headshot_100.jpg?itok=_VMhD0hM&c=fca690c28f3148226ba10bf3df52390c)
Adele Jones
![](https://pdtueu.com/sites/default/files/styles/panopoly_image_square/public/speakers/glas_data_launchpadacmatt_jessop_4.jpg?itok=Ut0gi4a0&c=416d113218d4fdf302444bc8b12c240d)
Robert Sanders
Rob is a farmer’s son from the southwest of the UK, with a background in software focusing on architecture and AI. Rob founded Glas Data in 2018 to specifically address the challenge of data management in agriculture. Glas Data’s products look to improve access to information for everyone in the sector and provide a single hub where ALL information can be analysed and aggregated. Rob’s vision is a unified data language for the agri sector so we can truly unlock precision farming.
![](https://pdtueu.com/sites/default/files/styles/panopoly_image_square/public/speakers/fiona_headshot.jpg?itok=u-UiCk_Z&c=a8a279b893471878c81eca508da84e50)